Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel I Feig

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Plos One|December 8, 2025
Dosing trajectories of antihypertensive agents among preterm neonates: A retrospective, cross-sectional analysisMary-Carty Pittman, Alejandro D Perez, Kaniz Afroz Tanni, et al.
Plos One|April 22, 2025
Sequence of antihypertensive medications used in preterm infants with hypertension: A cross-sectional studyAlejandro D Perez, Mary-Carty Pittman, Kaniz Afroz Tanni, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 17, 2018
Subclinical inflammation phenotypes and long-term outcomes after pediatric kidney transplantationMichael E Seifert, Megan V Yanik, Daniel I Feig, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 25, 2018
Phase I study of single-dose pharmacokinetics and pharmacodynamics of belatacept in adolescent kidney transplant recipientsAsha Moudgil, Vikas R Dharnidharka, Daniel I Feig, et al.
The American Journal of Clinical Nutrition|October 9, 2007
Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular diseaseRichard J Johnson, Mark S Segal, Yuri Sautin, et al.
Clinical Kidney Journal|August 2, 2023
Sugar, salt, immunity and the cause of primary hypertensionLaura G Sánchez-Lozada, Magdalena Madero, Marilda Mazzali, et al.
Pediatric Transplantation|May 25, 2019
CYP3A5 genotype affects time to therapeutic tacrolimus level in pediatric kidney transplant recipientsMegan V Yanik, Michael E Seifert, Jayme E Locke, et al.
Pediatric Rheumatology Online Journal|November 16, 2018
Rituximab treatment for chronic steroid-dependent Henoch-Schonlein purpura: 8 cases and a review of the literatureCourtney B Crayne, Esraa Eloseily, Melissa L Mannion, et al.
Nature Reviews. Nephrology|July 13, 2019
The case for uric acid-lowering treatment in patients with hyperuricaemia and CKDYuka Sato, Daniel I Feig, Austin G Stack, et al.
Nature Reviews. Nephrology|April 22, 2020
Reply to 'The case for evidence-based medicine for the association between hyperuricaemia and CKD'Yuka Sato, Daniel I Feig, Austin G Stack, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Plos One|December 8, 2025
Dosing trajectories of antihypertensive agents among preterm neonates: A retrospective, cross-sectional analysisMary-Carty Pittman, Alejandro D Perez, Kaniz Afroz Tanni, et al.
Plos One|April 22, 2025
Sequence of antihypertensive medications used in preterm infants with hypertension: A cross-sectional studyAlejandro D Perez, Mary-Carty Pittman, Kaniz Afroz Tanni, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 17, 2018
Subclinical inflammation phenotypes and long-term outcomes after pediatric kidney transplantationMichael E Seifert, Megan V Yanik, Daniel I Feig, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 25, 2018
Phase I study of single-dose pharmacokinetics and pharmacodynamics of belatacept in adolescent kidney transplant recipientsAsha Moudgil, Vikas R Dharnidharka, Daniel I Feig, et al.
The American Journal of Clinical Nutrition|October 9, 2007
Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular diseaseRichard J Johnson, Mark S Segal, Yuri Sautin, et al.
Clinical Kidney Journal|August 2, 2023
Sugar, salt, immunity and the cause of primary hypertensionLaura G Sánchez-Lozada, Magdalena Madero, Marilda Mazzali, et al.
Pediatric Transplantation|May 25, 2019
CYP3A5 genotype affects time to therapeutic tacrolimus level in pediatric kidney transplant recipientsMegan V Yanik, Michael E Seifert, Jayme E Locke, et al.
Pediatric Rheumatology Online Journal|November 16, 2018
Rituximab treatment for chronic steroid-dependent Henoch-Schonlein purpura: 8 cases and a review of the literatureCourtney B Crayne, Esraa Eloseily, Melissa L Mannion, et al.
Nature Reviews. Nephrology|July 13, 2019
The case for uric acid-lowering treatment in patients with hyperuricaemia and CKDYuka Sato, Daniel I Feig, Austin G Stack, et al.
Nature Reviews. Nephrology|April 22, 2020
Reply to 'The case for evidence-based medicine for the association between hyperuricaemia and CKD'Yuka Sato, Daniel I Feig, Austin G Stack, et al.
Pageof 7